Advanced treatment of receptor-positive breast cancer

Hot Topics in Oncology ◽

10.4147/hto-110800 ◽

2012 ◽

Author(s):

Grazia Arpino ◽

Valentina Guarneri ◽

PierFranco Conte

Keyword(s):

Breast Cancer ◽

Advanced Treatment ◽

Positive Breast Cancer

Download Full-text

Abstract P6-18-10: A phase 1b/2 study of ribociclib plus trastuzumab for the treatment of advanced, treatment-refractory HER2-positive breast cancer

10.1158/1538-7445.sabcs18-p6-18-10 ◽

2019 ◽

Author(s):

S Goel ◽

L Spring ◽

R Rees ◽

C Andrews ◽

RK Tahara ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Treatment ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Phase 1B ◽

Treatment Refractory ◽

Positive Breast Cancer

Download Full-text

A phase III trial to determine the activity and safety of fulvestrant (Faslodex®) in premenopausal women with oestrogen-receptor positive breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(02)80305-7 ◽

2002 ◽

Vol 38 (11) ◽

pp. S97 ◽

Author(s):

J Robertson

Keyword(s):

Breast Cancer ◽

Oestrogen Receptor ◽

Premenopausal Women ◽

Phase Iii ◽

Phase Iii Trial ◽

Positive Breast Cancer

Download Full-text

Diagnostic delay is more frequent in triple negative breast cancer than in hormone receptor-positive breast cancer

10.1055/s-0040-1710602 ◽

2020 ◽

Author(s):

S Baumgartner ◽

U Güth ◽

K Reeve ◽

C Elfgen

Keyword(s):

Breast Cancer ◽

Triple Negative Breast Cancer ◽

Hormone Receptor ◽

Triple Negative ◽

Diagnostic Delay ◽

Hormone Receptor Positive ◽

Positive Breast Cancer

Download Full-text

Review of treatment strategies for HER2 positive breast cancer and their implementation in a major Swiss hospital

10.1055/s-0040-1710671 ◽

2020 ◽

Author(s):

F Geissler ◽

M Vetter ◽

A Schoetzau ◽

C Montavon ◽

C Kurzeder ◽

...

Keyword(s):

Breast Cancer ◽

Treatment Strategies ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with neoadjuvant chemotherapy: Sequential analysis

10.26226/morressier.596dfd55d462b80292386fa4 ◽

2017 ◽

Author(s):

You-Jeong Seo

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Sequential Analysis ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Pik3ca Mutations ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Hypoxia up-regulates ID proteins in Luminal and HER2-positive breast cancer cell lines

10.26226/morressier.5b4709836f4cb30010951ad8 ◽

2018 ◽

Author(s):

Gloria Peiro Cabrera

Keyword(s):

Breast Cancer ◽

Cancer Cell ◽

Breast Cancer Cell ◽

Breast Cancer Cell Lines ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Id Proteins ◽

Positive Breast Cancer Cell ◽

Positive Breast Cancer

Download Full-text

FDA approves fam-trastuzumab deruxtecan-nxki for unresectable or metastatic HER2-positive breast cancer

Case Medical Research ◽

10.31525/cmr-24bd324 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

FDA approves new treatment option for patients with HER2-positive breast cancer who have progressed on available therapies

Case Medical Research ◽

10.31525/cmr-24bb59f ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Treatment Option ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

New Treatment ◽

Positive Breast Cancer

Download Full-text

FDA approves new treatment option for patients with HER2-positive breast cancer who have progressed on available therapies

Case Medical Research ◽

10.31525/cmr-24bb467 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Treatment Option ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

New Treatment ◽

Positive Breast Cancer

Download Full-text

Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Chemotherapy in Patients With HER2 Positive Breast Cancer

Case Medical Research ◽

10.31525/ct1-nct03847818 ◽

2000 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text